|
1
|
Tesfaye B, Alebel A, Gebrie A, Zegeye A,
Tesema C and Kassie B: The twin epidemics: Prevalence of TB/HIV
co-infection and its associated factors in Ethiopia; A systematic
review and meta-analysis. PLoS One. 13(e0203986)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yuan FS, Liu L, Liu LH, Zeng YL, Zhang LL,
He F, Liu XJ, Li JM, Liu Q, Xu MJ, et al: Epidemiological and
spatiotemporal analyses of HIV/AIDS prevalence among older adults
in Sichuan, China between 2008 and 2019: A population-based study.
Int J Infect Dis. 105:769–775. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vrinceanu D, Dumitru M, Patrascu OM,
Costache A, Papacocea T and Cergan R: Current diagnosis and
treatment of rhinosinusal aspergilloma (review). Exp Ther Med.
22(1264)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tola A, Mishore KM, Ayele Y, Mekuria AN
and Legese N: Treatment outcome of tuberculosis and associated
factors among TB-HIV Co-infected patients at public hospitals of
Harar town, eastern Ethiopia. A five-year retrospective study. BMC
Public Health. 19:1–12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tiberi S, Carvalho AC, Sulis G, Vaghela D,
Rendon A, Mello FC, Rahman A, Matin N, Zumla A and Pontali E: . The
cursed duet today: Tuberculosis and HIV-coinfection. Presse Med.
46:e23–e39. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liebenberg C, Luies L and Williams AA:
Metabolomics as a tool to investigate HIV/TB co-infection. Front
Mol Biosci. 8(692823)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Vecchione MB, Laufer N, Sued O, Corti M,
Salomon H and Quiroga MF: 7-oxo-DHEA enhances impaired M.
tuberculosis-specific T cell responses during HIV-TB coinfection. J
Biomed Sci. 27(20)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schutz C, Meintjes G, Almajid F, Wilkinson
RJ and Pozniak A: Clinical management of tuberculosis and HIV-1
co-infection. Eur Respir J. 36:1460–1481. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Musisi E, Matovu DK, Bukenya A, Kaswabuli
S, Zawedde J, Andama A, Byanyima P, Sanyu I, Sessolo A, Seremba E,
et al: Effect of anti-retroviral therapy on oxidative stress in
hospitalized HIV-infected adults with and without TB. Afr Health
Sci. 18:512–522. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lu DY, Wu HY, Yarla NS, Xu B, Ding J and
Lu TR: HAART in HIV/AIDS treatments: Future trends. Infect Disord
Drug Targets. 18:15–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang H, Wang Y, Guo PJ, Wu YM, Gao Y, Li
XC, Gao BC, Liu J, Li H and Yang JY: Analysis of the effect of
antiretroviral therapy and drug resistance in adult AIDS in inner
Mongolia, China: A comprehensive study. J Biol Regul Homeost
Agents. 36:783–787. 2022.
|
|
12
|
Proal AD and Marshall TG: Re-framing the
theory of autoimmunity in the era of the microbiome: Persistent
pathogens, autoantibodies, and molecular mimicry. Discov Med.
25:299–308. 2018.PubMed/NCBI
|
|
13
|
Sereti I, Sheikh V, Shaffer D, Phanuphak
N, Gabriel E, Wang J, Nason MC, Roby G, Ngeno H, Kirui F, et al:
Prospective international study of incidence and predictors of
immune reconstitution inflammatory syndrome and death in people
living with human immunodeficiency virus and severe lymphopenia.
Clin Infect Dis. 71:652–660. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Arirachakaran P, Luangworakhun S,
Charalampakis G and Dahlén G: Non-oral, aerobic, Gram-negative
bacilli in the oral cavity of Thai HIV-positive patients on
Highly-active anti-retrovirus therapy medication. J Investig Clin
Dent. 10(e12387)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pean P, Nouhin J, Ratana M, Madec Y,
Borand L, Marcy O, Laureillard D, Fernandez M, Barré-Sinoussi F,
Weiss L, et al: High Activation of γδ T cells and the
γδ2pos T-cell subset is associated with the onset of
tuberculosis-associated immune reconstitution inflammatory
syndrome, ANRS 12153 CAPRI NK. Front Immunol.
10(2018)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Quinn CM, Poplin V, Kasibante J, Yuquimpo
K, Gakuru J, Cresswell FV and Bahr NC: Tuberculosis IRIS:
Pathogenesis, presentation, and management across the spectrum of
disease. Life (Basel). 10(262)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Namale PE, Abdullahi LH, Fine S, Kamkuemah
M, Wilkinson RJ and Meintjes G: Paradoxical TB-IRIS in HIV-infected
adults: A systematic review and meta-analysis. Future Microbiol.
10:1077–1099. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Cevaal PM, Bekker LG and Hermans S:
TB-IRIS pathogenesis and new strategies for intervention: Insights
from related inflammatory disorders. Tuberculosis (Edinb).
118(101863)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barber DL, Andrade BB, Sereti I and Sher
A: Immune reconstitution inflammatory syndrome: The trouble with
immunity when you had none. Nat Rev Microbiol. 10:150–156.
2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chang C, Sheikh V, Sereti I and French MA:
Immune reconstitution disorders in patients with HIV infection:
From pathogenesis to prevention and treatment. Curr HIV/AIDS Rep.
11:223–232. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu J, Yamane H and Paul WE:
Differentiation of effector CD4 T cell populations. Ann Rev
Immunol. 28:445–489. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zheng Y, Zhou H, He Y, Chen Z, He B and He
M: The immune pathogenesis of immune reconstitution inflammatory
syndrome associated with highly active antiretroviral therapy in
AIDS. AIDS Res Hum Retroviruses. 30:1197–1202. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Duan Y, Bai H, Li X, Wang D and Wang Y,
Cao M, Zhang N, Chen H and Wang Y: Oncolytic adenovirus H101
synergizes with radiation in cervical cancer cells. Curr Cancer
Drug Targets. 21:619–630. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Stephensen CB, Marquis GS, Douglas SD,
Kruzich LA and Wilson CM: Glutathione, glutathione peroxidase, and
selenium status in HIV-positive and HIV-negative adolescents and
young adults. Am J Clin Nutr. 85:173–181. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ivanov AV, Valuev-Elliston VT, Ivanova ON,
Kochetkov SN, Starodubova ES, Bartosch B and Isaguliants MG:
Oxidative stress during HIV infection: Mechanisms and consequences.
Oxid Med Cell Longev. 2016(8910396)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Awodele O, Olayemi SO, Nwite JA and
Adeyemo TA: Investigation of the levels of oxidative stress
parameters in HIV and HIV-TB co-infected patients. J Infect Dev
Ctries. 6:79–85. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rosa AC, Corsi D, Cavi N, Bruni N and
Dosio F: Superoxide dismutase administration: A review of proposed
human uses. Molecules. 26(1844)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Makinde O, Rotimi K, Ikumawoyi V, Adeyemo
T and Olayemi S: Effect of vitamin A and vitamin C supplementation
on oxidative stress in HIV and HIV-TB co-infection at Lagos
University Teaching Hospital (LUTH) Nigeria. Afr Health Sci.
17:308–314. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Safe IP, Amaral EP, Araújo-Pereira M,
Lacerda MV, Printes VS, Souza AB, Beraldi-Magalhães F, Monteiro WM,
Sampaio VS, Barreto-Duarte B, et al: Adjunct N-acetylcysteine
treatment in hospitalized patients with HIV-associated tuberculosis
dampens the oxidative stress in peripheral blood: Results from the
RIPENACTB study trial. Front Immunol. 11(602589)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen L, Wang X, Jia X, Lan Y, Yi H, Wang X
and Xu P: Investigation of 3-year inpatient TB cases in Zunyi,
China: Increased TB burden but improved bacteriological diagnosis.
Front Public Health. 10(941183)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
AIDS and Hepatitis C Professional Group,
Society of Infectious Diseases, Chinese Medical Association and
Chinese Center for Disease Control and Prevention. Chinese
guidelines for diagnosis and treatment of HIV/AIDS (2018). Zhonghua
Nei Ke Za Zhi. 57:867–884. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
Meintjes G, Lawn SD, Scano F, Maartens G,
French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler
C, et al: Tuberculosis-associated immune reconstitution
inflammatory syndrome: Case definitions for use in resource-limited
settings. Lancet Infect Dis. 8:516–523. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Melgar M, Nichols C, Cavanaugh JS, Kirking
HL, Surie D, Date A, Ahmedov S, Maloney S and Fukunaga R: CDC
Country Offices' Tuberculosis/HIV Advisors et al.
Tuberculosis preventive treatment scale-up among antiretroviral
therapy patients-16 countries supported by the U.S. president's
emergency plan for AIDS relief, 2017-2019. MMWR Morb Mortal Wkly
Rep. 69:329–334. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ji YJ, Liang PP, Shen JY, Sun JJ, Yang JY,
Chen J, Qi TK, Wang ZY, Song W, Tang Y, et al: Risk factors
affecting the mortality of HIV-infected patients with pulmonary
tuberculosis in the cART era: a retrospective cohort study in
China. Infect Dis Poverty. 7(25)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wu Y, Chen J and Lu H: Advances in the
study of the development of immunodeficiency inflammatory syndrome
in people infected with mycobacteria tuberculosis combined with the
human immunodeficiency virus. Chin J Inf Chemo. 18:230–235.
2018.(In Chinese).
|
|
36
|
Surur AS, Teni FS, Wale W, Ayalew Y and
Tesfaye B: Health related quality of life of HIV/AIDS patients on
highly active anti-retroviral therapy at a university referral
hospital in. Ethiopia. 17(737)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bauer DC, Black DM, Bouxsein ML, Lui LY,
Cauley JA, de Papp AE, Grauer A, Khosla S, McCulloch CE and Eastell
R: Foundation for the National Institutes of Health (FNIH) Bone
Quality Project. Treatment-related changes in bone turnover and
fracture risk reduction in clinical trials of anti-resorptive
drugs: A meta-regression. J Bone Miner Res. 33:634–642.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kleinman AJ, Sivanandham R, Pandrea I,
Chougnet CA and Apetrei C: Regulatory T cells as potential targets
for HIV cure research. Front Immunol. 9(734)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
De Biasi S, Bianchini E, Nasi M, Digaetano
M, Gibellini L, Carnevale G, Borghi V, Guaraldi G, Pinti M, Mussini
C and Cossarizza A: Th1 and Th17 proinflammatory profile
characterizes invariant natural killer T cells in virologically
suppressed HIV+ patients with low CD4+/CD8+ ratio. AIDS.
13:2599–2610. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Qu YZ, Li M, Zhao YL, Zhao ZW, Wei XY, Liu
JP, Gao L and Gao GD: Astragaloside IV attenuates cerebral
ischemia-reperfusion-induced increase in permeability of the
blood-brain barrier in rats. Eur J Pharmacol. 606:137–141.
2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Li Y and Sun W: . Effects of Th17/Treg
cell imbalance on HIV replication in patients with AIDS complicated
with tuberculosis. Experimental and Therapeutic Medicine.
15:2879–83. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sun L and Liu Y: Clinical factors of blood
transfusion-related acute lung injury and changes in levels of
Treg-related cytokines. Emerg Med Int. 2022(7344375)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhou M, Zhang Y, Tang R, Liu H, Du M, Gao
Z, Ji Z and Fang H: HMGB1/TLR4 signaling affects regulatory T cells
in acute lung injury. J Inflamm Res. 14:1551–1561. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Nadeem A, Al-Harbi NO, Ahmad SF, Al-Harbi
MM, Alhamed AS, Alfardan AS, Assiri MA, Ibrahim KE and Albassam H:
Blockade of interleukin-2-inducible T-cell kinase signaling
attenuates acute lung injury in mice through adjustment of
pulmonary Th17/Treg immune responses and reduction of oxidative
stress. Int Immunopharmacol. 83(106369)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yang J, Yang X, Zou H and Li M: Oxidative
stress and Treg and Th17 dysfunction in systemic lupus
erythematosus. Oxid Med Cell Longev. 2016:1–9. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yang Y, Xia J, Yang Z, Wu G and Yang J:
The abnormal level of HSP70 is related to Treg/Th17 balance in PCOS
patients. J Ovarian Res. 14(155)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lee GR: The Balance of Th17 versus Treg
Cells in Autoimmunity. Int J Mol Sci. 19(730)2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Littman DR and Rudensky AY: Th17 and
regulatory T cells in mediating and restraining inflammation. Cell.
140:845–858. 2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Tyagi P, Pal VK, Agrawal R, Singh S,
Srinivasan S and Singh A: Mycobacterium tuberculosis
reactivates HIV-1 via exosome-mediated resetting of cellular redox
potential and bioenergetics. mBio. 11(e03293)2020.PubMed/NCBI View Article : Google Scholar
|
